- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
California lawmakers have asked the governor to sign legislation that sources say could allow the state to manufacture and distribute mifepristone widely across the country via telehealth if the abortion medication is pulled from the market following an ongoing FDA review of safety data sparked by a controversial, non-peer-reviewed study.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us